Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection

This protocol has been withdrawn

view version history

Information

DOI:
https://doi.org/10.1002/14651858.CD009390.pub2Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 02 February 2018see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:

  1. Cochrane HIV/AIDS Group

Copyright:
  1. Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Mario Cruciani

    Correspondence to: Antibiotic Stewardship Programme, Azienda ULSS9 Scaligera, Verona, Italy

    [email protected]

  • Arturo J Martí‐Carvajal

    Iberoamerican Cochrane Network, Valencia, Venezuela

  • Carlo Mengoli

    Department of Histology, Microbiology and Medical Biotechnology, Università di Padova, Padova, Italy

  • Giovanni Serpelloni

    Dipartimento delle Dipendenze, ULSS 20 Verona, 37135 Verona, Italy

  • Chiara Bovo

    Direzione Sanitaria, Azienda ULSS 20, Verona, Italy

  • Graeme Moyle

    Department of HIV and Genitourinary Medicine, Chelsea and Westminster Hospital, London, UK

Version history

Published

Title

Stage

Authors

Version

2018 Feb 02

Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection

Protocol

Mario Cruciani, Arturo J Martí‐Carvajal, Carlo Mengoli, Giovanni Serpelloni, Chiara Bovo, Graeme Moyle

https://doi.org/10.1002/14651858.CD009390.pub2

2011 Nov 09

Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection

Protocol

Mario Cruciani, Arturo J Martí‐Carvajal, Carlo Mengoli, Giovanni Serpelloni, Chiara Bovo, Graeme Moyle

https://doi.org/10.1002/14651858.CD009390